Background
The role of infection in the pathogenesis of atherosclerosis is still a matter of debate.
Aims
This study aimed to investigate the effect of CagA-positive Helicobacter pylori (H. pylori) strains infection on coronary atherosclerosis in patients with coronary heart disease and to elucidate how cytotoxin-associated
gene A (CagA)-positive H. pylori strains infections were involved in coronary heart disease by examining the levels of serum lipid, high-sensitivity C-reactive
protein (hsCRP) and oxidized low-density protein (oxLDL).
Methods
Recruited for this study were 159 patients with coronary heart disease. The severity of coronary heart disease was estimated
by calculating the Gensini score. Serum oxLDL and hsCRP were examined in all subjects. Current H. pylori infection was determined in all participants by means of a modified (13C) urea breath test (>200 dpm classified as positive).
IgG antibodies against CagA protein were analyzed by enzyme immunoassays. Antibody titers against CagA (≥8 U/ml) were classified
as positive. All subjects were divided into three groups, including an uninfected group (n = 30), an H. pylori
+CagA− group (n = 69), and an H. pylori
+CagA+ group (n = 60).
Results
Significant differences were found among the three groups in levels of total cholesterol, low-density lipoprotein cholesterol,
apolipoprotein B, serum hsCRP, oxLDL, and severity of coronary atherosclerosis (p < 0.05). The levels of total cholesterol, LDL, apolipoprotein B, serum hsCRP, oxLDL were significantly elevated and the severity
of coronary atherosclerosis was significantly increased in H. pylori
+CagA+ group (p < 0.05).
Conclusions
More serious coronary atherosclerosis was observed in CHD patients with H. pylori
+CagA+ infection. H. pylori
+CagA+ infection might be involved in coronary atherosclerosis by modifying serum lipids, enhancing LDL oxidation, and activating
the inflammatory responses.
Keywords
Helicobacter pylori
- Coronary atherosclerosis - Coronary heart disease - Lipid - C-reactive protein - Oxidized low-density protein